Home > National Drug Code (NDC) > Treatment Set TS345268

Treatment Set TS345268 - 49288-0843-3 - (Treatment Set TS345268)

Alphabetical Index


Drug Information of Treatment Set TS345268

Product NDC: 49288-0843
Proprietary Name: Treatment Set TS345268
Non Proprietary Name: Treatment Set TS345268
Active Ingredient(s): 20000; .01    [AU]/mL; g/mL & nbsp;   Treatment Set TS345268
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS345268

Product NDC: 49288-0843
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19861031

Package Information of Treatment Set TS345268

Package NDC: 49288-0843-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0843-3)

NDC Information of Treatment Set TS345268

NDC Code 49288-0843-3
Proprietary Name Treatment Set TS345268
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0843-3)
Product NDC 49288-0843
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Treatment Set TS345268
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19861031
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA TRIFIDA POLLEN
Strength Number 20000; .01
Strength Unit [AU]/mL; g/mL
Pharmaceutical Classes Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS345268


General Information